EUVIMEDEUVIMED entdecken
Crossref

Clozapine concentration and adverse reactions: Impact of smoking

Y. W. Francis Lam

The Brown University Psychopharmacology Update · 2026-03 · 37 (3) · 2-2

DOI: 10.1002/pu.31416 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Brown University Psychopharmacology Update, online erschienen am 23.02.2026. Verfasst von Y. W. Francis Lam. Die Arbeit nennt 2 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The atypical antipsychotic clozapine is uniquely efficacious in addressing treatment‐resistant schizophrenia. There are significant variations, however, in its pharmacokinetic profile among treated patients, resulting from altered metabolic capacity secondary to drug‐drug interaction and/or smoking status (Haring et al., 1989). Smoking cigarettes produces chemicals that act as potent inducers of the activity of CYP1A2, the primary enzyme responsible for the metabolism of clozapine to the active metabolite norclozapine.

Zitieren

APA

Lam, Y. W. F. (2026). Clozapine concentration and adverse reactions: Impact of smoking. The Brown University Psychopharmacology Update, 37(3), 2-2. https://doi.org/10.1002/pu.31416

Vancouver

Lam YWF. Clozapine concentration and adverse reactions: Impact of smoking. The Brown University Psychopharmacology Update. 2026;37(3):2-2. doi:10.1002/pu.31416

BibTeX
@article{Lam2026,
  author = {Lam, Y. W. Francis},
  title = {Clozapine concentration and adverse reactions: Impact of smoking},
  journal = {The Brown University Psychopharmacology Update},
  year = {2026},
  volume = {37},
  number = {3},
  pages = {2--2},
  doi = {10.1002/pu.31416}
}
Kostenlos starten →